Pulmonx Corporation (LUNG) NASDAQ
1.61
+0.02(+1.26%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.61
+0.02(+1.26%)
Currency In USD
| Market Cap | 89.92M |
| Enterprise Value | 76.27M |
| P/E Ratio | -1.27 |
| PEG Ratio | -0.12 |
| Price/Sales Ratio | 0.77 |
| Price/Book Ratio | 1.47 |
| Enterprise/Revenue | 0.71 |
| Enterprise/EBITDA | -1.27 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.6 |
| Operating Margin | -0.59 |
| Return On Assets | -0.44 |
| Return On Equity | -0.93 |
| Revenue | 90.5M |
| Revenue/Share | 2.11 |
| Gross Profit | 67.14M |
| EBITDA | -52.61M |
| Net Income | -54M |
| Diluted EPS | -1.33 |
| Total Cash | 61.57M |
| Total Cash/Share | 1.47 |
| Total Debt | 56.29M |
| Total Debt/Equity | 1.23 |
| Current Ratio | 4.91 |
| Book Value Per Share | 1.09 |
| 52-Week Change | -48.56 |
| 52-Week High | 3.88 |
| 52-Week Low | 1.13 |
| Moving Average 50 Days | 1.36 |
| Moving Average 200 Days | 1.67 |
| Average Volume | 553,838 |
| Shares Outstanding | 42.24M |
| % Held by Institutions | 76.68 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |